GENLISA™ Mouse Anti-SARS-CoV-2 (Covid-19) IgG Antibody to Spike RBD protein Quantitative TITRATION ELISA

This range of mouse ELISA is currently being used for pre-clinical assessment and validation of vaccines against SARS-CoV-2 including:

• Selection of a novel candidate
• Immunization studies
• Titration of antibodies – toxicology
• Other in-vitro studies

These specifically designed ELISA can be used for different kinds of vaccines being developed in the industry - specific for S1, S2 or RBD; both mRNA based, and DNA based.

About the SARS-CoV-2 Mouse IgG to Spike RBD Assay:

• Based on monoclonal antibody detection for better sensitivity. A sandwich ELISA design and highly specific antibodies (rated highly specific in a study done by PATH) allow for a robust ELISA with low cross reactivity.
• Standard, ready-to-use protocol
• The option to run serum or plasma samples
• Ships in 2 days at ambient temperature
• Developed against seven-step validation process, as per ICH and FDA guidelines for biological assays
• Calibrator Range: 0 ng/ml - 720 ng/ml
• Sensitivity: 12 ng/ml
• Sample Type: Serum, Plasma
• Reactivity: Mouse
• Shipping Condition: 2 - 8 Deg C
• Detection Method: Colorimetric
• Usage: For Research Use Only
• Research Area: COVID-19